UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER

SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION

OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Commission File Number:   000-30380

DIABETEX INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

350 Kachina Circle

Las Vegas, Nevada 89123

(702) 492-9413

(Address, including zip code and telephone number, including area code, of

registrant's principal executive offices)

COMMON STOCK, $0.002 PAR VALUE

(Title of each class of securities covered by this Form)

NONE

(Titles of all other classes of securities for which a duty to file reports

under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)	[  ]	Rule 12h-3(b)(1)(i)	[  ]
Rule 12g-4(a)(1)(ii)	[X]	Rule 12h-3(b)(1)(ii)	[  ]
Rule 12g-4(a)(2)(i)	[  ]	Rule 12h-3(b)(2)(i)	[  ]
Rule 12g-4(a)(2)(ii)	[  ]	Rule 12h-3(b)(2)(ii)	[  ]
		Rule 15d-6	[  ]

Approximate number of holders of record as of the certification or notice date: 425

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	DIABETEX INTERNATIONAL CORP.
Dated: June 27, 2005	By:/s/  Dr. Eugene Koppenhaver                                             Dr. Eugene Koppenhaver, President

- 2 -